Medplus Health Services Limited — Investor Meet, 16-11-2024: Analysts/Institutional Investor Meet/Con. Call Updates

1. **Financial Performance:** MedPlus Health Services reported consolidated revenue of ₹15,762 million, reflecting an 11.9% increase year-on-year and a 5.9% rise quarter-on-quarter. The operating EBITDA reached ₹739 million, marking a 4.7% margin, while pharmacy operations contributed significantly, with an 18.4% growth in revenue year-on-year. Notably, stores older than 12 months achieved a store-level EBITDA margin of 10.2%.

2. **Future Outlook and Growth Drivers:** Management indicated a strong focus on expanding the store network, targeting a total of 600 new stores this fiscal. So far, 463 net new stores have been added in the last year, with an emphasis on tier 2 cities. The private label product share is expected to increase, contributing positively to revenue growth and margin enhancement.

3. **Order Book and Operational Updates:** The company currently operates 4,552 stores, with a strategic expansion in tier 2 cities, which represent a growing portion of pharmacy revenue. Store additions in Q2 included 132 openings, reflecting a strategy to capitalize on the growth potential in less saturated markets.

4. **Analyst Q&A Insights:**

- **Revenue and Profitability:** Analysts sought clarity on sustaining the 2Q gross margin expansion attributed to private label growth. Management remains optimistic, foreseeing consistent margins supported by operational efficiencies.

- **Market Position and Competitive Landscape:** The entry of quick commerce players prompted discussions on competition. Management expressed readiness to monitor developments while maintaining an established market presence.

- **Operational Challenges or Risks:** Concerns about inventory management were addressed, highlighting the need to balance stock levels with customer demand to avoid lost sales.

- **Capex and Capital Allocation:** Discussion around free cash flow highlighted that careful management of store openings could enhance cash generation despite planned expansions.

- **Strategic Priorities and Long-Term Vision:** The company's plan to broaden its online presence and improve private label offerings suggests a robust long-term growth strategy.

5. **Market or Regulatory Updates:** No specific regulatory updates were discussed, but management's awareness of the evolving competitive landscape suggests a proactive approach to potential market changes.

6. **Strategic Focus Areas:** Key themes include focusing on private label products for margin enhancement, proactive store expansion in new markets, and a gradual approach to online sales, reflecting management's adaptability within a competitive market.

7. **Investor Insight:** The financial performance and management's growth focus indicate a favorable outlook for investors. The combination of solid revenue growth, margin improvement through private label products, and strategic expansion in tier 2 cities supports a potential ‘buy’ positioning, given the anticipated positive cash flow and growth in market share.